Substrate binding enzyme: coenzyme: inhibitor complex

Substrate binding also induces a conformational change in this enzyme. When both coenzymes and substrate bind the "closed" conformation of the enzyme is formed by a rotation of the catalytic domains of the two subunits relative to the coenzyme-binding do-mains.50 51a Structures of ternary complexes with inhibitors and with substrates have also been established. 

The mechanism of the overall reaction between LADH, NADH, and an aldehyde has been reported to proceed via formation of a LADH-NADH complex followed by reaction with substrate, according to studies on the unproductive LADH-substrate complex formed between enzyme and 4-(2-imidazolylazo)benzaldehyde.237 Substrate-and coenzyme-competitive inhibitors displace the azo-aldehyde, showing that the site of binding overlaps those of normal substrate and coenzyme. There is no reaction with the azo-aldehyde unless prior binding of coenzyme occurs. 

Kinetic studies of reversible inhibition by substrate analogs give evidence of the mode of action of the inhibitor and the types of enzyme-inhibitor complex formed, and estimates of their dissociation constants. The complexes may be isolated and sometimes crystallized. Studies of the stabilities, optical properties, and structures of ternary complexes of enzymes, coenzymes, and substrate analog in particular, as stable models of the catalytically active ternary complexes or of the transition state for hydride transfer (61,79,109,115-117), can only be touched upon here there is direct evidence with several enzymes that the binding of coenzymes is firmer in such complexes than in their binary complexes (85,93,118), which supports the indirect, kinetic evidence already mentioned for a similar stabilization in active ternary complexes. 

A number of conformationally restricted fluorinated inhibitors have been synthesized and evaluated. These smdies show that (1) subtle conformational differences of the substrates affect the inhibition (potency, reversible or irreversible character) (Figure 7.50), (2) a third inhibition process involving an aromatization mechanism could take place (Figure 7.51). When the Michael addition and enamine pathways lead to a covalently modified active site residue, the aromatization pathway produces a modified coenzyme able to produce a tight binding complex with the enzyme, responsible for the inhibition (Figure 7.51). ... 

However, the findings (171) that binary complexes of zinc-free enzyme and coenzyme bind substrates and substrate competitive inhibitors such as isobutyramide cannot be taken as evidence that zinc does not participate in the catalytic action. Several SH groups are probably oxidized in the zinc-free enzyme (170). Evidence has also been presented (172) of other structural differences compared to the catalytically active enzyme. Thus, artificial binding to this enzyme with no relevance to the catalytic action is not unlikely. 

Enzyme complexes of substrates, coenzymes, and inhibitors are the simplest complexes to study for the purpose of gaining information on the manner in which the enzymes facilitate catalytic action. Usually one looks for changes either in P-NMR spectral parameters and J) or in dynamical parameters (line shape and T,) of the substrate (inhibitor or analogs) nuclei on binding the enzyme and on making further specified additions to the complexes or making modifications to the enzyme, and so on. Results of this type on several different enzyme systems are discussed. 

---